These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 12397524
1. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day]. Gosepath J, Schäfer D, Mann WJ. Laryngorhinootologie; 2002 Oct; 81(10):732-8. PubMed ID: 12397524 [Abstract] [Full Text] [Related]
2. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy. Pfaar O, Klimek L. J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950 [Abstract] [Full Text] [Related]
3. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis. Schapowal AG, Simon HU, Schmitz-Schumann M. Acta Otorhinolaryngol Belg; 1995 Dec; 49(3):235-50. PubMed ID: 7484142 [Abstract] [Full Text] [Related]
4. [Self-desensitization with aspirin in a patient with aspirin intolerance]. Rozsasi A, Keck T. Laryngorhinootologie; 2009 Aug; 88(8):540-1. PubMed ID: 19562656 [No Abstract] [Full Text] [Related]
8. Aspirin intolerance: does desensitization alter the course of the disease? Klimek L, Pfaar O. Immunol Allergy Clin North Am; 2009 Nov; 29(4):669-75. PubMed ID: 19879442 [Abstract] [Full Text] [Related]
9. [Nasal polyps is not a homogenous pathology]. Arcimowicz M, Balcerzak J, Samoliński BK. Pol Merkur Lekarski; 2005 Sep; 19(111):276-9. PubMed ID: 16358841 [Abstract] [Full Text] [Related]
10. [Allergy and intolerance to nonsteroidal antinflammatory drugs: successful desensitization in three cases]. Cardona R, Ramírez RH, Reina Z, Escobar MF, Morales E. Biomedica; 2009 Jun; 29(2):181-90. PubMed ID: 20128343 [Abstract] [Full Text] [Related]
11. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation. Rossini R, Angiolillo DJ, Musumeci G, Scuri P, Invernizzi P, Bass TA, Mihalcsik L, Gavazzi A. Am J Cardiol; 2008 Mar 15; 101(6):786-9. PubMed ID: 18328841 [Abstract] [Full Text] [Related]
12. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease. Chen JR, Buchmiller BL, Khan DA. J Allergy Clin Immunol Pract; 2015 Mar 15; 3(6):926-31.e1. PubMed ID: 26282158 [Abstract] [Full Text] [Related]
13. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases. Fraj J, Valero A, Vives R, Pérez I, Borja J, Izquierdo I, Picado C. Allergy; 2008 Jan 15; 63(1):112-5. PubMed ID: 18053020 [Abstract] [Full Text] [Related]
14. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. Katial RK, Strand M, Prasertsuntarasai T, Leung R, Zheng W, Alam R. J Allergy Clin Immunol; 2010 Oct 15; 126(4):738-44. PubMed ID: 20728206 [Abstract] [Full Text] [Related]
16. [Polyposis of the nasal sinuses. Epidemiology and clinical aspects of 350 cases. Treatment and results with a follow-up over 5 years on 93 cases]. Braun JJ, Haas F, Conraux C. Ann Otolaryngol Chir Cervicofac; 1992 Oct 15; 109(4):189-99. PubMed ID: 1485748 [Abstract] [Full Text] [Related]